Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
27.71
-0.19 (-0.68%)
Sep 10, 2026, 1:27 PM EDT - Market open
Hims & Hers Health Market Cap
Hims & Hers Health has a market cap or net worth of $6.47 billion as of September 10, 2026. Its market cap has decreased by -40.15% in one year.
Market Cap
6.47B
Enterprise Value
7.17B
1-Year Change
-40.15%
Ranking
Category
Stock Price
$27.71
ChartMarket Cap Chart
Since September 13, 2019, Hims & Hers Health's market cap has increased from $246.53M to $6.47B, an increase of 2,522.43%. That is a compound annual growth rate of 59.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 6.47B | -12.54% |
| Dec 31, 2025 | 7.39B | 39.92% |
| Dec 31, 2024 | 5.28B | 180.00% |
| Dec 29, 2023 | 1.89B | 41.69% |
| Dec 30, 2022 | 1.33B | -0.30% |
| Dec 31, 2021 | 1.34B | 263.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 15.77B |
| Elanco Animal Health | 11.77B |
| Dr. Reddy's Laboratories | 10.01B |
| Alkermes | 7.62B |
| Lantheus Holdings | 6.57B |
| Liquidia | 6.19B |
| Kiniksa Pharmaceuticals International, | 6.13B |
| Amneal Pharmaceuticals | 6.01B |